Steven Cohen’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Steven Cohen’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-789,100	Closed	-$5.26M	–	3003
2023 Q3	$5.26M	Sell	789,100 -1,140,067	-59%	-$9.48M	0.02%	863
2023 Q2	$17.5M	Sell	1,929,167 -1,185,194	-38%	-$10.5M	0.05%	423
2023 Q1	$22.6M	Sell	3,114,361 -83,204	-3%	-$617K	0.07%	320
2022 Q4	$23.3M	Sell	3,197,565 -495,055	-13%	-$3.67M	0.08%	305
2022 Q3	$28.5M	Buy	3,692,620 +1,738,391	+89%	+$14.8M	0.11%	238
2022 Q2	$13.3M	Buy	1,954,229 +1,911,961	+4,523%	+$14.6M	0.06%	431
2022 Q1	$337K	Buy	+42,268	New	+$268K	﹤0.01%	1042
2021 Q2	–	Sell	-375,000	Closed	-$3.94M	–	1220
2021 Q1	$3.94M	Buy	+375,000	New	+$5.09M	0.02%	620

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Steven Cohen's PNT Position: Q4 2023 in Review

Steven Cohen sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 789,100 shares — an estimated $5.26M sold.

Steven Cohen first reported a position in PNT in Q1 2021 and held it in 8 quarters. The position peaked at $28.5M in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Steven Cohen reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Steven Cohen sold 789,100 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $5.26M.
Steven Cohen first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Steven Cohen's POINT Biopharma Global Inc. Common Stock position peaked at $28.5M in Q3 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.